Ofelia Alvarez is an Oncology physician affiliated with University of Miami. OpenAlex indexes 121 publications with 4,633 citations (h-index 33); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1601 NW 12th Ave
Miami, FL 331016960
Telephone
305-243-4029Registry record last updated 30 Jan 2013.
Clinical trials
- Propanolol and Red Cell Adhesion Non-asthmatic Children Sickle Cell Disease
Sponsor: University of Miami
- Liver Fibrosis in Sickle Cell Disease
Sponsor: University of Miami
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Genetix Biotherapeutics IncProgram year20251 payment
- PFIZER INC.Program year20251 payment
- PFIZER INC.Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
100%Hemoglobin S Polymerization Inhibitor100%Oxbryta100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2012–2023 per NIH RePORTER. The latest:
- Comparative Study of Haitian and Miami Cohorts of Haitian-American and Haitian Immigrant Children with Sickle Cell Disease (CSHSCD)
University of Miami School of Medicine
FY2023$398,668R01HL149121 - Comparative Study of Haitian and Miami Cohorts of Haitian-American and Haitian Immigrant Children with Sickle Cell Disease (CSHSCD)
University of Miami School of Medicine
FY2022$549,085R01HL149121 - Comparative Study of Haitian and Miami Cohorts of Haitian-American and Haitian Immigrant Children with Sickle Cell Disease (CSHSCD)
University of Miami School of Medicine
FY2021$544,972R01HL149121
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis
Expert Review of Hematology
2022 - Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease center
Pediatric Blood & Cancer
2022 - Stroke and stroke prevention in sickle cell anemia in developed and selected developing countries
Journal of the Neurological Sciences
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Myerburg, MD
University of Miami
Thomas Hooton, MD
University of Miami
Harry Flynn, MD
University of Miami
Alan Wein, MD
University of Miami
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”